Target intelligence / Profile preview

Ventral intermediate nucleus of thalamus (VIM)

Target
VIM
Molecular classification
Other (Thalamic motor relay nucleus; not a receptor, enzyme, ion channel, or classical molecular target)
01

Overview

The ventral intermediate nucleus of the thalamus (VIM) is a major motor relay nucleus within the lateral thalamic group, specifically connecting the cerebellum and thalamus with the motor cortex as part of the cerebello-thalamo-cortical network. It is critically involved in the modulation and relay of movement signals. The VIM is a validated and widely used target for stereotactic surgical procedures such as deep brain stimulation (DBS) and focused ultrasound ablation (FUS) to treat movement disorders, particularly essential tremor and tremor-predominant Parkinson's disease. The nucleus is anatomically bordered by other thalamic nuclei involved in motor and sensory processing, making precise targeting essential to avoid adverse effects. There are no known drugs targeting the VIM at the molecular level; rather, its significance is as a surgical and electrophysiological target rather than a classical molecular target like receptors or enzymes[1][4][5][6].

Other names
Ventral intermediate nucleusVIM nucleus
02

Mechanism of action

Lesioning/ablation (e.g., focused ultrasound thalamotomy): Reduces pathological tremor by disrupting abnormal neuron firing in the VIM[1][6] Deep brain stimulation: Alters neuronal firing patterns, modulating motor output and reducing tremor symptoms[4][5][6]

03

Biological functions

Motor signal relayModulation of movementIntegration within the cerebello-thalamo-cortical network
04

Disease associations

Neurodegenerative diseaseTremor (including essential tremor and tremor-dominant Parkinson's disease)
05

Safety considerations

Risk of motor or sensory adverse effects if adjacent thalamic structures are damaged[1][4]Paraesthesia and weakness if stimulation or lesioning encroaches border nuclei (e.g., ventral caudal nucleus, internal capsule)[1][4]Chorea if inferior border is ablated (zona incerta/posterior subthalamic area)[1]

Beyond the preview

Go deeper on Ventral intermediate nucleus of thalamus (VIM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ventral intermediate nucleus of thalamus (VIM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call